We have already shown that forestomach lesions induced by 24 weeks administration of genotoxic carcinogens, 8-nitroquinoline (8-NQ), 2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide (AF-2), N-methyl-N'-nitro-Nnitrosoguanidine (MNNG) or N-methylnitrosourethane (MNUR), do not regress within 24 weeks of cessation of the chemical exposure. In contrast, simple or papillary hyperplasias induced by 24 weeks administration of non-genotoxic carcinogens, butylated hydroxyanisole (BHA), caffeic acid (CA), sesamol or 4-methoxyphenol (4-MP), largely disappear. In the present study, to examine the mechanisms of the reversibility of proliferative forestomach lesions, representative non-genotoxic carcinogens, BHA, CA or 4-MP, and one genotoxic carcinogen, MNUR, were given to male F344 rats for 24 weeks, then their forestomachs were sequentially analyzed after withdrawal of the chemical insult. MNUR-induced proliferative lesions such as hyperplasias, papillomas and squamous cell carcinomas did not regress and the expression level of cell cycle regulators, cyclin D1 and p27 were not altered after cessation of the chemical insult. On the other hand, BHA-, CA-or 4-MP-induced hyperplasias clearly regressed, in association with reduction of cyclin D1 expression. During this process, expressions of p27 and cleaved caspase 3 were not altered. These findings suggest that regression of proliferative lesions induced by non-genotoxic rat forestomach carcinogens is controlled partially by a positive cell cycle regulator, cyclin D1, whereas dysregulation of this mechanism is a characteristic of the irreversible lesions induced by a genotoxic carcinogen. (J Toxicol Pathol 2008; 21: 77-87) 
Introduction
It is generally accepted that there are two types of carcinogens, genotoxic and non-genotoxic, with quite different biological consequences. In rodent carcinogenesis studies, most early lesions induced by non-genotoxic carcinogens, such as hyperplasias, show reversibility when the chemical insult is withdrawn, whereas the lesions induced by genotoxic carcinogens tend to be nonreversible [1] [2] [3] . Even a single exposure to a genotoxic carcinogen may induce malignant tumors in some cases [4] [5] [6] , but it usually needs long-term exposure to induce malignant tumors with non-genotoxic carcinogens 7 -1 0 . Cell proliferation is an important factor in the production of tumors by both genotoxic and non-genotoxic carcinogens 11 . It is possible that the nature of these proliferative changes differ, but this largely remains to be clarified. For a better understanding of biological differences between reversible and irreversible lesions, it is useful to compare examples induced by genotoxic and non-genotoxic carcinogens.
The alkylating agent N-methylnitrosourethane (MNUR) has been reported to have mutagenic selectivity 12 and induce squamous cell carcinomas (SCCs) in 82% of male F344 rat forestomachs by oral administration at a dose of 20 ppm in drinking water for 48 weeks 2 . Butylated hydroxyanisole (BHA), caffeic acid (CA) and 4-methoxyphenol (4-MP) are phenolic compounds; BHA has previously been used as a food additive. These compounds possess carcinogenic activity in the rat forestomach epithelium in 2-year administration at a dose of 2% in diet without apparent genotoxicity. The incidences of forestomach SCCs in male F344 rats treated long-term with BHA, CA and 4-MP were 34% 7 , 77% 1 3 and 77% 8 ,
respectively. We have already demonstrated that forestomach proliferative lesions, such as hyperplasias and papillomas, induced by 24 weeks administration of genotoxic carcinogens, 8-nitroquinoline (8-NQ), 2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide (AF-2), N-methyl-N'-nitro-Nnitrosoguanidine (MNNG) or MNUR, do not regress, but rather progress to neoplastic and increasingly malignant lesions 24 weeks after cessation of the chemical exposure 2 . In contrast, simple or papillary hyperplasias induced by 24 weeks administration of non-genotoxic forestomach carcinogens, BHA, CA, sesamol or 4-MP were found to clearly regress within 24 weeks of cessation of the treatment 2 . However, atypical hyperplasias appear to persist after cessation of treatment, regardless of the type of carcinogen 2 . Kaneko et al. demonstrated that MNNG-and MNUR-induced rat forestomach tumors frequently feature H-ras and p53 gene mutations as well as overexpression of cyclin D1 and p53, whereas BHA-or CA-induced tumors had almost no mutations in these genes and lower expression of cyclin D1 and p53 14 . These findings suggest that the cell kinetics of the forestomach lesions induced by genotoxic carcinogens and non-genotoxic carcinogens are differently regulated.
In the rat urinary bladder, calculi-associated papillomatosis induced by 15 weeks feeding of uracil, which is a non-genotoxic carcinogen, disappears 15 weeks after cessation of the treatment 15 . During this regression process, reduction of cyclin D1 expression and increase of p27 expression 16 , as well as induction of apoptosis 17 can be clearly observed. On the other hand, in irreversible tumors induced by uracil after initiation of genotoxic N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN), persistent low expression of p27 and elevated cyclin D1 were evident, even after cessation of the proliferation stimulus due to uracil calculi 16 . Thus, there are also clear differences in cell cycle regulation between proliferating lesions induced by non-genotoxic uracil alone and those observed after initiation with genotoxic BBN in the rat urinary bladder.
The cell cycle is controlled by many factors 18 , including cyclins and cyclin-dependent kinases (Cdk), which positively drive the process of cell division, and Cdk inhibitors such as p27 kip1 , p21 waf1 , p16 INK4a and p15 INK4b , which act as negative regulators, affecting the Rb gene phosphorylation status which governs progression from the G1 to the S phase 19 . Of these, cyclin D1, one of the G1 cyclins, is highly expressed in B cell neoplasms (known as BCL-1), breast and squamous cell carcinomas of the head and neck, and is regarded as an oncogene in man 20 . Since it has been reported that Samd 4 and PTEN double mutant mice exhibit accelerated spontaneous forestomach tumorigenesis and decreased expression of p27, p21 and p16, together with overexpression of cyclin D1 21 , it is likely that expression of these factors strongly relates to forestomach carcinogenesis.
Cell death due to apoptosis clearly affects normal physiological and pathogenetic processes, such as development and protective responses to DNA damage, and is controlled by many factors in mammalian cells 22, 23 . The caspase family serially forms a signaling cascade, and cleavage of caspase 3 which acts as an effector is considered as one of the ultimate regulatory steps 24 . In the present study, to cast light on the mechanisms of the reversibility of hyperplastic lesions induced by nongenotoxic carcinogens and a genotoxic carcinogen after cessation of chemical treatment, a rat forestomach model was used to sequentially compare the expression of cell cycle regulators, such as cyclin D1 and p27, and the apoptosis-related element, cleaved caspase 3 (C-caspase 3).
Materials and Methods

Animals and chemicals
Male F344 rats at 5 weeks of age were purchased from Charles River Japan Inc. (Kanagawa, Japan), and acclimated for approximately 1 week. They were housed five per plastic cage with wood chips for bedding in an air-conditioned room at 22 ± 2°C and 55 ± 5% relative humidity with a 12-h light/ dark cycle. They were given Oriental MF diet (Oriental Yeast Co., Japan) and water ad libitum until used for the experiment.
The genotoxic carcinogen, MNUR, was purchased from Tokyo Kasei Kogyo, Co. (Tokyo, Japan), and administered at a concentration of 20 ppm in the drinking water. The non-genotoxic carcinogens tested were BHA and 4-MP, purchased from Wako Pure Chemical Industries (Osaka, Japan), and CA from Tokyo Kasei Kogyo, Co. The purities of these chemicals were certified as more than 98%. Each was mixed with Oriental MF powdered basal diet to provide a concentration of 2%. Animals in this experiment were treated in accordance with the Guidelines for the Care and Use of Laboratory Animals of Nagoya City University Graduate School of Medical Sciences.
Experimental design
The experimental design is shown in Fig. 1 . Starting at 6 weeks of age, groups of 30 rats were treated with 20 ppm MNUR in the drinking water, 2% BHA in the diet, 2% CA in the diet, or 2% 4-MP in the diet for 24 weeks. Immediately after completing the chemical treatment at week 24, 5 rats from each group were sacrificed, and this point was assigned as day 0. The remaining rats were maintained on basal diet and tap water. Then, at 1, 3, 7, 14 and 28 days after cessation of the chemical treatment, 5 rats from each treatment group were sacrificed for the investigation. Control rats were given basal diet alone and 5 rats were sacrificed at the same time points as for the chemical treatment groups. All rats were weighed once a week during the chemical treatment period and at the time of sacrifice. Food consumption was measured once every 4 weeks during the chemical treatment.
For the histopathological analysis, both ends of the removed stomachs were tied, then 10% buffered formalin was carefully injected into the lumen. After a few minutes, the stomachs were cut along the greater curvature, then placed within folded filter papers to flatten the tissue during further fixation. Six longitudinal sections were cut from the anterior and posterior walls of each forestomach including the limiting ridge, routinely processed and stained with h e m a t o x y l i n a n d e o s i n ( H & E ) , a s w e l l a s b y immunohistochemistry. Following the guidelines established previously 6, 25 , lesions were microscopically classified into erosion/ulcer as a result of toxicity, and hyperplasia, papilloma and SCC as focal proliferative lesions. The thickness of the epithelium in the prefundic and mid regions in each forestomach strip was measured at maximal thickness by light microscopy using an eyepiece containing grid lines in each section, and the average for each rat was calculated.
For immunohistochemical analysis, paraffin sections were incubated with anti-PCNA (PC-10, Dako, Glostrup, Denmark), anti-Ki67 (NCL-Ki67p, Novocastra laboratories, Newcastle upon Tyne, United Kingdom), anti-cyclin D1 (Immunobiological Laboratories, Gunma, Japan), anti-p27 (C-19, Santa Cruz Biotechnology, Santa Cruz, CA, USA), and anti-C-caspase 3 (Asp175, Cell Signaling Technology, Danvers, MA, USA) antibodies at dilutions of 50, 500, 1000, 100 and 500 times, respectively. A Vectastain ABC elite Kit (Vector Laboratories Inc., Burlingame, CA, USA) and DAB were used for visualization. For the analysis of PCNApositivity, 100 cells in each section within the most pronounced hyperplastic lesions of the prefundic and mid regions, excepting papillomas and carcinomas, were counted (a total of 600 cells in each rat). For analysis of cell cycle regulators, Ki67, cyclin D1 and p27, and the apoptosisrelated C-caspase 3, positive cells in normal-looking, nonneoplastic (hyperplasia) and neoplastic regions (papillomas and SCCs) were separately counted, up to 1000 epithelial cells in each lesion, then % values were calculated as a labeling index (LI).
Statistics
Means with standard deviations were calculated for each group. According to the number of subjects, data were analyzed by Bartlett's method (the level of significance = 1%, two-tailed test) or the F test (the level of significance = 5%, two-tailed test). For homogenous data, mean values were compared between the basal diet group and each chemical treatment group by Dunnett's or Student's t-test. For the heterogeneous data, mean values were compared by a Dunnett-type rank test or Aspin-Welch's t-test. For the labeling indices of cyclin D1, p27 and C-caspase 3 in each mucosal lesion, differences between the mean values on day 0 and each day after the cessation of chemical treatment were examined by a paired t-test.
Results
Body weights on week 1 did not significantly differ among the groups, but were relatively low from week 4 to 24 in all chemically treated groups as compared to the basal diet group. Food consumption in week 1 in the 4-MP and MNUR groups was lower than in the basal diet group, BHA and CA groups, but there was no significant variation at later time points (data not shown).
Macroscopically, at week 24, MNUR-and CA-induced forestomach nodular or patchy lesions were evenly distributed throughout the entire forestomach epithelium. BHA-induced lesions were predominantly found around the prefundic region which showed whitish thickening of the prefundic limiting ridge. 4-MP-induced lesions were circular ulcers with mucosal thickening in the mid region. These findings were in line with previously reported results 26 . Representative macroscopic appearances of rat forestomachs after treatment with MNUR, BHA, CA or 4-MP for 24 weeks and 28 days after cessation of treatment are illustrated in Fig. 2 . MNUR-induced hyperplasias and papillomas were observed in all animals at all time points (Fig. 2a and 2b) . BHA-or CA-induced hyperplasias were observed near the limiting ridge (Fig. 2c ) or mid region (Fig.  2e ), but at 28 days after cessation of non-genotoxic carcinogen treatment, these had disappeared and the areas appeared normal (Fig. 2d and 2f ). 4-MP-induced hyperplasia and ulceration/erosion were observed in the mid region (Fig 2g) , but at 28 days after cessation of 4-MP treatment only basal cell hyperplasia remained (Fig. 2h) . 4-MP-induced hyperplasia is characterized by basal cell rather than spinous cell proliferation 2, 8 . The incidences of histopathological lesions are summarized in Table 1 . Papillomas were observed in all animals and SCCs were found in 2, 3 and 2 of 5 rats at days 0, 1 and 14, respectively, in the MNUR group. Papillomas were also observed in single rat in the CA group at days 7 and 14, but no papillomas or SCCs were apparent in the BHA and 4-MP groups at any time point. Erosion/ulceration in the mid region was observed in all animals at days 0 to 3, 2 animals at day 7, and was absent at days 14 and 28 in the 4-MP group, and 1 to 3 rats at days 0, 3, 7 and 14 in the CA group. This lesion was not observed in the MNUR and BHA groups.
In the MNUR group (Fig. 3a) , the average thickness of the epithelium demonstrated significantly higher values than those in the basal diet group throughout the recovery period, even on day 28 (P<0.01). In the non-genotoxic CA, 4-MP and BHA groups (Fig. 3a,b) , the values sequentially decreased with the recovery period and showed significance from day 14 compared to day 0 (P<0.05, 0.01 and 0.01, respectively), but the thickness in the 4-MP group was still significantly higher than that of the basal diet group on day 28 (P<0.01). PCNA LIs in the MNUR group also remained elevated throughout the recovery period with statistical significance (P<0.01 vs. basal diet group) (Fig. 4) . In the 4-MP group, the LIs gradually decreased showing statistical significance from day 7 (P<0.01 vs. day 0), but were higher than in the CA group throughout the recovery periods, and significantly higher than the control value even on day 28 (P<0.01). In the CA and BHA groups, PCNA LIs rapidly decreased showing statistical significance from days 3 and 1 (both P<0.01 vs. day 0), respectively, and had decreased to approximately the control level on day 3. Ki67 LIs showed similar trends to PCNA LIs in hyperplasias within both the prefundic and mid regions in all chemical treatment groups (data not shown).
Cell cycle regulators and apoptosis signaling were separately evaluated and compared in normal-looking and hyperplastic regions (Fig. 5, Table 2-5) . Compared with the value of basal diet group at each time point, cyclin D1 LIs and p27 LIs in papillomas and hyperplasias of all the treated groups were increased. Most of these values showed significant differences. In the MNUR group (Fig. 5a and Table 2 ), cyclin D1 LIs in both hyperplasias and papillomas remained high regardless of the recovery periods, and those in papillomas were higher than in hyperplasias. p27 LIs in this group also remained elevated and were significantly (P<0.05) higher on day 28 than the value on day 0, in both hyperplasia and papillomas, while C-caspase 3 LIs stayed almost equal to the control levels, and were significantly decreased on days 14 and 28 relative to the value on day 0 in hyperplasias (P<0.05). In the non-genotoxic carcinogen groups (Fig. 5b-d and Table 3 -5), cyclin D1 LIs in hyperplasia on day 0 or 1 were highest, then gradually decreased with the process of recovery. The time points of the lowest values of cyclin D1 in hyperplasias differed among the chemical treatment groups: BHA (Fig. 5b and Table 3 ) on day 3 (P<0.05 vs. day 0), CA ( Fig. 5c and Table  4 ) on day 7 (P<0.01 vs. day 0), and 4-MP ( Fig. 5d and Table  5 ) on day 14 (P<0.01 vs. day 0). In addition, cyclin D1 LIs in CA-induced hyperplasia tended to increase on days 14 and 28, as compared with 7 days after cessation, and that in 4-MP-induced hyperplasia showed a significant increase on day 28 (P<0.05), as compared with the lowest value on day 14. p27 LIs in hyperplasias were generally higher than in normal-looking regions in the non-genotoxic carcinogen groups at all time points. C-caspase 3 LIs in all groups were similar in hyperplasias and normal-looking regions throughout the recovery periods, although values in hyperplasias observed on days 3 and 7 were lower than on 
Discussion
In the present experiment, papillomas and SCCs were observed in all and 7 of 30 rats administered MNUR, respectively. As in a previous experiment, in which papillomas and SCCs did not regress but rather progressed 24 weeks after cessation of MNUR treatment 2 , these lesions appeared irreversible. On the other hand, in non-genotoxic carcinogen treatment groups, although complete regression was not observed within 28 days, the incidence or grade of hyperplasias as evaluated by the mucosal thickness clearly decreased after cessation of the chemical insult. In the 4-MP group, regression tended to be delayed but this appeared related to the involvement of basal cell components 2 . Cell proliferative responses including regression are known to be . The present study demonstrated that epithelial thickness and PCNA LI of the non-genotoxic carcinogen groups were higher than the basal diet group on day 0, and were associated with accelerated expression of cyclin D1, as well as negative cell cycle regulator, p27, regardless of the type of proliferative lesions. These tendencies were more obvious in hyperplasias than in normal-looking mucosa. Immediately after cessation of the chemical treatments, PCNA LIs and expression of cyclin D1 decreased followed by reduction of the mucosal thickness. Since expression of p27 was already high on day 0, and remained elevated throughout the regression process, clear alteration of expression of p27 was not observed even after cessation. Moreover, the fact that neither histopathological apoptotic body (data not shown) nor induction of the main apoptosis regulator, C-caspase 3, were observed throughout the experimental period suggests that apoptosis was not a major mechanism of regression of the hyperplastic lesions in the rat forestomachs. The findings observed in the rat forestomach were different from our previous reversibility study on the rat urinary bladder. In the hyperplastic lesions induced by a non-genotoxic carcinogen, uracil, (proliferative stimuli: bladder calculi) showed clear elevation of cyclin D1 and slight reduction of p27. Reduction of cyclin D1 and elevation of p27 16 as well as induction of apoptosis 17 was apparently observed immediately after the cessation of proliferative stimuli, uracil administration. Thus, during the induction and regression of hyperplastic lesions, positive cell cycle regulators, such as cyclin D1 might play a dominant role in the rat forestomach, while positive regulators as well as negative regulators, including p27, cooperatively act in the urothelium. However, the possible contribution of other negative cell cycle regulators such as p21 and p16 needs to be elucidated.
Cell proliferation ability expressed as BrdU LIs of the forestomach is approximately 5-20%, while that of the urothelium is less than 0.2% in the male F344 rat 28 . Thus, forestomach epithelial cells are classified as rapidly proliferating cells (like intestinal epithelium and skin) and urothelial cells are slowly proliferating cells (also lung, liver, kidney, prostate and spinal cord) 29, 30 . Myers et al. reported that the percentage of p27-expressing androgen-dependent human prostatic adenocarcinoma (CWR22) cells inoculated into male nude mice was increased by castration 31 . It was also reported that castration-induced atrophy of the rat ventral prostate was associated with a significant increase in p27 expression, while regeneration induced by testosterone propionate stimuli was associated with a significant drop in p27 expression 32 . Increase in p27 expression was also observed in regression of antiprogestin-induced mouse mammary carcinoma cells (59-2-HI and C7-2-HI) when they were transplanted to the female BALB/c mice subcutis 33 . These facts suggest that the altered regulation of p27 seen in the rapidly proliferating forestomach epithelium and in the slowly proliferating urothelium, prostate epithelium and mammary epithelium during the regression process might be related to differences in basic cell kinetics.
Both in the present study of the rat forestomach and the previous investigation of the rat urinary bladder 16 , dysregulation of normal responses characterized by reduction of cyclin D1 was universally observed in genotoxic carcinogen-induced irreversible lesions. Dysregulated expression of cell cycle regulators has also been reported in human preneoplastic esophageal dysplasia 34 . Further analysis of the mechanisms of the continuous expression of cyclin D1 or perturbation of the cell cycle after cessation of proliferating stimuli thus appears warranted.
In conclusion, our results suggest that regression of hyperplastic lesions induced by non-genotoxic carcinogens in the rat forestomach is controlled partially by the positive cell cycle regulator, cyclin D1, dysregulation of this mechanism being characteristic of the irreversible lesions induced by a genotoxic carcinogen.
